Johnson & Johnson 2022 Full Year

Height

Spacing

Font

Prefix

Suffix

Canvas

2022

Full Year Q4

Company name

Fiscal year

Reporting period

Consumer health [14.953][15.035] Revenue
Immunology [16.935][16.75] Pharmaceutical
Infectious diseases [5.449][5.825] Pharmaceutical
Neuroscience [6.893][6.988] Pharmaceutical
Oncology [15.983][14.548] Pharmaceutical
Pulmonary [3.417][3.45] Pharmaceutical
Other pharma [3.887][4.119] Pharmaceutical
Pharmaceutical [52.563][51.68] Revenue
Medical devices [27.427][27.06] Revenue
Interventional [4.3][3.971] Medical devices
Orthopaedics [8.587][8.588] Medical devices
Surgery [9.69][9.812] Medical devices
Vision [4.849][4.688] Medical devices
Revenue [63.854][63.92] Gross profit
Revenue [31.089][29.855] Cost of revenue
Gross profit [23.382][] Operating profit
Gross profit [24.765][26.1] SG&A
Gross profit [14.603][15.4] R&D
Gross profit [0.783][0.9] In-process R&D
Gross profit [0.321][0.252] Restructuring
Interest income [0.214][] Net profit
Operating profit [17.727][20.878] Net profit
Operating profit [1.871][0.489] Other
Operating profit [3.784][1.898] Tax
:Consumer health #696969 [false]   [false]  
:Cost of revenue #ac0300 [false]   [false]  
:Gross profit #00ac03 [false]   [true] Flat Y/Y
:Immunology #696969 [false]   [true]  
:In-process R&D #ac0300 [false]   [false]  
:Infectious diseases #696969 [false]   [true]  
:Interest income #00ac03 [true] $214M  [false]  
:Interventional #696969 [false]   [true]  
:Medical devices #696969 [false]   [false]  
:Net profit #00ac03 [false]   [false]  
:Neuroscience #696969 [false]   [true]  
:Oncology #696969 [false]   [true]  
:Operating profit #00ac03 [false]   [false]  
:Orthopaedics #696969 [false]   [true]  
:Other #ac0300 [false]   [false]  
:Other pharma #696969 [false]   [true]  
:Pharmaceutical #696969 [false]   [false]  
:Pulmonary #696969 [false]   [true]  
:R&D #ac0300 [false]   [false]  
:Restructuring #ac0300 [true] $321M   [true]  
:Revenue #696969 [false]   [false]  
:SG&A #ac0300 [false]   [false]  
:Surgery #696969 [false]   [true]  
:Tax #ac0300 [false]   [false]  
:Vision #696969 [false]   [true]

[["Vision",[0,0.08997449648386986]],["Surgery",[0,0.07581456447790391]],["Medical devices",[0,0.12592495198610104]],["Orthopaedics",[0,0.06748710150603758]],["Interventional",[0,0.05859051618087484]],["Pharmaceutical",[0,0.04355088776862491]],["Other pharma",[0,0.025391602037380074]],["Pulmonary",[0,0.01752181325991764]],["Oncology",[0,0.020333916644096398]],["Neuroscience",[0,0.019743295026557913]],["Infectious diseases",[0,0.023913786198036423]],["Immunology",[0,0.014359544775015737]],["Cost of revenue",[0,0.21769369480764617]],["Revenue",[0,0.11715116893762363]],["Operating profit",[0,-0.020683773103645442]],["Net profit",[0,-0.027546340786495007]],["Other",[0,0.011366847980693618]],["Consumer health",[0.049544099610002355,-0.026385615551950445]],["Interest income",[0.04081972236570763,-0.6011560693641619]],["In-process R&D",[0,0.03856314361300158]],["R&D",[0,0.016340503205829006]],["SG&A",[0,0.010674001579867871]],["Tax",[0,0.056353706921251204]],["Gross profit",[0,0.04571376979875661]],["Restructuring",[0,0.08285163776493257]]]

SankeyArt Pro

Custom canvas size

Advanced Settings

2022